AU2003902354A0 - Treatment of haemorrhagic shock - Google Patents

Treatment of haemorrhagic shock

Info

Publication number
AU2003902354A0
AU2003902354A0 AU2003902354A AU2003902354A AU2003902354A0 AU 2003902354 A0 AU2003902354 A0 AU 2003902354A0 AU 2003902354 A AU2003902354 A AU 2003902354A AU 2003902354 A AU2003902354 A AU 2003902354A AU 2003902354 A0 AU2003902354 A0 AU 2003902354A0
Authority
AU
Australia
Prior art keywords
treatment
haemorrhagic shock
haemorrhagic
shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003902354A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARKIN D
Original Assignee
HARKIN D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HARKIN D filed Critical HARKIN D
Priority to AU2003902354A priority Critical patent/AU2003902354A0/en
Publication of AU2003902354A0 publication Critical patent/AU2003902354A0/en
Priority to JP2006529441A priority patent/JP2006528208A/ja
Priority to EP04732886A priority patent/EP1635857A1/en
Priority to CA002557615A priority patent/CA2557615A1/en
Priority to PCT/AU2004/000642 priority patent/WO2004100975A1/en
Priority to AU2004238089A priority patent/AU2004238089A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003902354A 2003-05-15 2003-05-15 Treatment of haemorrhagic shock Abandoned AU2003902354A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2003902354A AU2003902354A0 (en) 2003-05-15 2003-05-15 Treatment of haemorrhagic shock
JP2006529441A JP2006528208A (ja) 2003-05-15 2004-05-14 コンプリメント５ａ受容体阻害剤を使用する出血ショックの処置
EP04732886A EP1635857A1 (en) 2003-05-15 2004-05-14 TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS
CA002557615A CA2557615A1 (en) 2003-05-15 2004-05-14 Treatment of haemorrhagic shock using complement 5a receptor inhibitors
PCT/AU2004/000642 WO2004100975A1 (en) 2003-05-15 2004-05-14 TREATMENT OF HAEMORRHAGIC SHOCK USING COMPLEMENT 5a RECEPTOR INHIBITORS
AU2004238089A AU2004238089A1 (en) 2003-05-15 2004-05-14 Treatment of haemorrhagic shock using complement 5a receptor inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003902354A AU2003902354A0 (en) 2003-05-15 2003-05-15 Treatment of haemorrhagic shock

Publications (1)

Publication Number Publication Date
AU2003902354A0 true AU2003902354A0 (en) 2003-05-29

Family

ID=31501223

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003902354A Abandoned AU2003902354A0 (en) 2003-05-15 2003-05-15 Treatment of haemorrhagic shock

Country Status (5)

Country Link
EP (1) EP1635857A1 (ja)
JP (1) JP2006528208A (ja)
AU (1) AU2003902354A0 (ja)
CA (1) CA2557615A1 (ja)
WO (1) WO2004100975A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG172338A1 (en) 2008-12-22 2011-07-28 Chemocentryx Inc C5ar antagonists
SI2585064T1 (sl) 2010-06-24 2017-08-31 Chemocentryx, Inc. Antagonisti C5AR
ES2926828T3 (es) 2014-09-29 2022-10-28 Chemocentryx Inc Procesos e intermedios en la preparación de antagonistas de C5aR
US20170202821A1 (en) 2016-01-14 2017-07-20 Chemocentryx, Inc. Method of treating c3 glomerulopathy
NZ747259A (en) 2016-04-04 2022-11-25 Chemocentryx Inc Soluble c5ar antagonists
KR102638253B1 (ko) 2017-05-31 2024-02-16 케모센트릭스, 인크. C5a 억제제로서의 6-5 융합 고리
BR112019025230A2 (pt) 2017-05-31 2020-06-16 Chemocentryx, Inc. Anéis 5-5 fundidos como inibidores de c5a
EP3703687A4 (en) 2017-10-30 2021-04-07 ChemoCentryx, Inc. DEUTERATED COMPOUNDS USED AS IMMUNOMODULATORS
AU2018388655C1 (en) 2017-12-22 2023-03-23 Chemocentryx, Inc. Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
US10759807B2 (en) 2017-12-22 2020-09-01 Chemocentryx, Inc. Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
US11608336B2 (en) 2018-04-02 2023-03-21 Chemocentryx, Inc. Prodrugs of fused-bicyclic C5aR antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist

Also Published As

Publication number Publication date
JP2006528208A (ja) 2006-12-14
WO2004100975A1 (en) 2004-11-25
EP1635857A1 (en) 2006-03-22
CA2557615A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
EG24420A (en) Treatment of ophthalmic conditions
AU2004203785A1 (en) Treatment of aqueous suspensions
AU2002257936A1 (en) Methods of well treatment
EP1617844A4 (en) TREATMENT OF NEUROLOGICAL DISEASES
AU2003902354A0 (en) Treatment of haemorrhagic shock
AU2003268923A1 (en) Treatment of aml
AU2002952086A0 (en) Treatment of osteoarthritis
AU2002952129A0 (en) Treatment of hypersensitivity conditions
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003238175A1 (en) Treatment of serious infections and septic shock
AU2003207315A1 (en) Treatment of muscle damage
GB0217493D0 (en) Novel methods of treatment
AU2003270615A1 (en) Treatment of steatosis using hyperthermia
GB0221712D0 (en) Methods of treatment
AU2003902586A0 (en) Treatment of burns
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003246977A1 (en) Oil well treatment
GB0327975D0 (en) Methods of treatment
AU2003281836A1 (en) Implant for the treatment of presbyopia
AU2003217862A1 (en) Treatment of septic shock
AU2003274359A1 (en) Treatment of fluids
AU2003271712A1 (en) Treatment of amm
AU2003904161A0 (en) Methods of treatment
AUPS219902A0 (en) Methods of treatment
AU2003260254A1 (en) Piece of jewelry